Saturday, April 27, 2024
Outlook.com
Outlook India
Outlook Business

Marathon Edge India Fund I Raises Stake In Newgen Software Technology

Abu Dhabi-based Al-Mehwar Commercial Investments LLC and India Acron Acv fund also bought shares of Newgen Software

Marathon Edge India Fund I Raises Stake In Newgen Software Technology
Pixabay
POSTED ON October 28, 2022 7:14 PM

Marathon Edge Partner-led Marathon Edge India Fund I has bought shares of Newgen Software by investing Rs 69 crore through an open market bulk deal. The fund managed to purchase 20 lakhs equity shares, with each share valued at an average price of Rs 345. 

This acquistion gives Marathon Edge India Fund I a 2.85 per cent stake in Newgen Software.

Abu Dhabi-based Al-Mehwar Commercial Investments LLC and India Acron Acv fund also bought the IT company's shares, picking up 5 lakh and 9 lakh shares respectively. 

Newgen Software's performance in FY 2022 has been dismal, with its shares providing negative 42 per cent returns. Even today, investors witnessed a drop of 0.58 per cent in the company's share prices.

Despite its poor performance in the stock market, the company managed to gain an increase in the Profit After Taxes (PAT) and net revenues. As per its results for the March quarter, 2022, it earned Rs 164 crore as PAT as compared to Rs 126.5 crore in the same period last year. In terms of revenue, the company witnessed a 16 percent year-on-year growth. 

  • Related Articles

    It was launched after a pilot in Lucknow last December, where Uber received a significant proportion of ride requests from new users, demonstrating potential product market fit

    Infobip’s AI-powered chatbot enables Delhi-NCR Uber users to book rides via WhatsApp

    Northern Arc plans to use half of the funds to provide financial assistance to MSMEs and women entrepreneurs in India

    FMO Invests $50 Million In Northern Arc

    Continuously raising funds, being top-heavy in terms of talent and unable to generate enough revenues to meet costs, these start-ups are spooking investors with their inability to justify their...

    Zombie Start-ups Give Investors The Shivers